Cases 31 - 40 of 100
Merck Sharp & Dohme Corp. v. Dr. Reddy's Laboratories, Inc. et al
as 1:2020cv00847
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Actavis LLC et al
as 1:2020cv00804
Defendant:
Hetero Labs Ltd., Belcher Pharmaceuticals, LLC, Glenmark Pharmaceuticals Ltd. and others
Plaintiff:
Sanofi Mature IP and Sanofi-Aventis U.S. LLC
Cause Of Action: 35 U.S.C. § 271
BIAL - PORTELA & CA. S.A. v. Dr. Reddy's Laboratories, Ltd. et al.
as 1:2020cv00784
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Plaintiff:
Bial - Holding, S.A., BIAL - PORTELA & CA. S.A. and Sunovion Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Genzyme Corp. et al v. Dr. Reddy's Laboratories, Inc. et al
as 1:2019cv02045
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Plaintiff:
The Regents of the University of Michigan and Genzyme Corp.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc. et al
as 1:2019cv02053
Defendant:
MSN Laboratories Private Limited, Dr. Reddys Laboratories, Inc., Hetero USA Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. v Dr. Reddy's Laboratories, Ltd. et al
as 1:2019cv01495
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Astellas US LLC et al v. Dr. Reddy's Laboratories, Ltd. et al
as 1:2019cv01160
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Plaintiff:
Gilead Sciences, Inc., Astellas US LLC and Astellas Pharma US, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
